CHINATRIALS+US brings together 100+ senior clinical development executives from Chinese innovative biotechs interested in conducting clinical trials in the US and US biotechs who have interest conducting clinical trials in or entering the China market.
The focus of discussion will be on the strategic and technical considerations these companies should consider when entering the US or China markets. We hope the synergies of bringing these two important groups together will introduce new opportunities for partnerships and collaborations for parallel drug development in the US and China.
REGISTRATION
BioPharma R&D Company Rate
$1,295 USD / 9,200 CNY Early Bird Rate by May 3, 2019 ($1,595 USD / 11,300 CNY after May 3, 2019)
If your company has a drug or device in preclinical/clinical development, or a product already on the market, you are eligible for the R&D rate.
BioPharma R&D Company Group Rates*
*If you are an R&D Company and your team is interested in sending multiple attendees, please email us at jon.liong@lycheegroup.com to register as a group. The group discounts are listed below.
Group Rate (2 or more attendees): $1,000 USD / 7,000 CNY per attendee
Standard Rate
$1,495 USD / 10,500 CNY Early Bird Rate by May 3, 2019 ($1,895 USD / 13,500 CNY after May 3, 2019)
If you are not eligible for the R&D Rate option listed above, you must select Standard Rate when registering.
注册参会
生物医药研发公司价格
1,295美金/9,200人民币（2019年5月3日后为1,595美金/11,300人民币）
如果您的公司已经拥有处于临床前/临床试验阶段的药物或医疗器械，或产品已经上市，您将可以享受研发公司价格。
生物医药研发公司团体注册优惠*
*如果您来自研发类公司并且您团队其他同事计划一起参会，请致信eric.lu@lycheegroup.com获取团体注册优惠价格。团体优惠价格如下：
团体价（2 人以上参会者）：1,000美金/ 7,000 人民币每人
标准注册参会费用
1,495美金/10,500人民币（2019年5月3日后为1,895美金/13,500人民币）
如果您的公司不属于的 “研发公司“范畴，在注册时您将只可以选择“标准注册参会费用“。
